We pay a high price in the stock market waiting for "certainty."
So when it comes to hunting for great stocks and big profits, it helps if we can put on our Sherlock Holmes "deerstalker" hats and use the powers of deduction and reasoning to infer a company's strategy.
In other words, watch what a company does, rather than the obvious stuff of what it says in its quarterly earnings announcements.
In the case of our portfolio's robotic surgery stock, we're already up more than 30% since I featured the company in the goodBUYreport newsletter 4 months ago.
More recently, the stock's held its own quite nicely despite a 10% correction in the small-cap Russell 2000 index.
Much like our tremendous success with Moderna (MRNA) - up 160% since the first newsletter writeup in March - I think we're just getting started with our position in the burgeoning next-generation technology of robotic surgery.
So I was very interested this morning when I saw an easily-dismissed press release.